The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (1-800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
BomannJ.S., PecklerB.F.Type IV renal tubular acidosis presenting as dyspnea in two older patients taking angiotensin-converting enzyme inhibitors. Ann Emerg Med.2002; 39: 73–6.
2.
DumanD., TurhalN.S., DumanD.G.Fatal aplastic anemia during treatment with ketoconazole [letter]. Am J Med.2001; 111: 737.
3.
KoenigA.S., AbruzzoJ.L.Lefluno-mide-induced fevers, thrombocytosis, and leukocytosis in a patient with relapsing polychondritis. J Rheumatol.2002; 29: 192–4.
4.
GabbayD.S., ChenS.M.Dystonia following administration of intravenous radiographic contrast material. J Emerg Med.2001; 21: 415–7.
5.
BrodeurM.R., StirlingAlDelirium associated with zolpidem. Ann Pharma-cother.2001; 35: 1562–4.
6.
RettmanK.S., McClintockC.Hepatotoxicity after short-term trazodone therapy. Ann Pharmacother.2001; 35: 1559–61.
